Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Milligan

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Clinical Immunology (Orlando, Fla.)|June 1, 2005
A soluble divalent class I MHC/IgG1 fusion protein activates CD8+ T cells in vivoBrenna Carey, Monica DeLay, Jane E Strasser, et al.
NPJ Vaccines|December 22, 2017
Research and development of Zika virus vaccinesBrian E Dawes, Claire A Smalley, Bethany L Tiner, et al.
NPJ Vaccines|March 18, 2022
Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and developmentMegan A Files, Clairissa A Hansen, Vanessa C Herrera, et al.
Plos One|May 5, 2015
A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 MiceGregg N Milligan, Vanessa V Sarathy, Ernesto Infante, et al.
The Journal of General Virology|September 27, 2017
A lethal model of disseminated dengue virus type 1 infection in AG129 miceGregg N Milligan, Vanessa V Sarathy, Mellodee M White, et al.
Journal of Virology|June 20, 2008
T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infectionDeepthi Kolli, Efthalia L Bataki, Leanne Spetch, et al.
Journal of Virology|November 14, 2014
A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic diseaseVanessa V Sarathy, Mellodee White, Li Li, et al.
Vaccine|September 21, 2014
Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 miceJeremy Fuchs, Haiyan Chu, Peter O'Day, et al.
Vaccine|January 10, 2012
Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signalingEvandro R Winkelmann, Douglas G Widman, Jingya Xia, et al.
The Journal of General Virology|August 23, 2015
Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse modelVanessa V Sarathy, Ernesto Infante, Li Li, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Clinical Immunology (Orlando, Fla.)|June 1, 2005
A soluble divalent class I MHC/IgG1 fusion protein activates CD8+ T cells in vivoBrenna Carey, Monica DeLay, Jane E Strasser, et al.
NPJ Vaccines|December 22, 2017
Research and development of Zika virus vaccinesBrian E Dawes, Claire A Smalley, Bethany L Tiner, et al.
NPJ Vaccines|March 18, 2022
Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and developmentMegan A Files, Clairissa A Hansen, Vanessa C Herrera, et al.
Plos One|May 5, 2015
A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 MiceGregg N Milligan, Vanessa V Sarathy, Ernesto Infante, et al.
The Journal of General Virology|September 27, 2017
A lethal model of disseminated dengue virus type 1 infection in AG129 miceGregg N Milligan, Vanessa V Sarathy, Mellodee M White, et al.
Journal of Virology|June 20, 2008
T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infectionDeepthi Kolli, Efthalia L Bataki, Leanne Spetch, et al.
Journal of Virology|November 14, 2014
A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic diseaseVanessa V Sarathy, Mellodee White, Li Li, et al.
Vaccine|September 21, 2014
Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 miceJeremy Fuchs, Haiyan Chu, Peter O'Day, et al.
Vaccine|January 10, 2012
Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signalingEvandro R Winkelmann, Douglas G Widman, Jingya Xia, et al.
The Journal of General Virology|August 23, 2015
Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse modelVanessa V Sarathy, Ernesto Infante, Li Li, et al.
Pageof 11